Chemoprotection from p53-dependent apoptosis: Potential clinical applications of the p53 inhibitors

Biochemical Pharmacology

Volumn 62, Issue 6, 2001, Pages 657-667

  Komarova, Elena A ^a   Gudkov, Andrei V ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Apoptosis; Cancer therapy; Hyperthermia; Ischemia; p53 Inhibitors

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT; APOPTOSIS INHIBITOR; CHAPERONE; CISPLATIN; CYTOSTATIC AGENT; DOXORUBICIN; GELDANAMYCIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; IFOSFAMIDE; METHOTREXATE; PIFITHRIN ALPHA; PROTEIN INHIBITOR; PROTEIN P53; PROTEIN P53 INHIBITOR; QUERCETIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIRTH DEFECT; BRAIN HYPOXIA; BURN; CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER THERAPY; CELL DAMAGE; CHEMOPROPHYLAXIS; DIGESTIVE SYSTEM; FEVER; GAMMA RADIATION; GENOTOXICITY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC SYSTEM; HUMAN; HYPERTHERMIC THERAPY; IATROGENIC DISEASE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SIDE EFFECT;

EID: 0035884487     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00733-X     Document Type: Review

References (156)

1. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice
2. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
3. Germline p53 mutations, and heritable cancer
4. Role of p53 in hematopoietic recovery after cytotoxic treatment
5. Gamma-ray-induced cell killing, and chromosome abnormalities in the bone marrow of p53-deficient mice
6. Apoptosis in bone marrow cells of mice with different p53 genotypes after gamma-rays irradiation in vitro
7. P53 deficiency produces fewer regenerating spermatogenic tubules after irradiation
8. p53 deficiency sensitizes clonogenic cells to irradiation in the large but not the small intestine
9. Apoptosis in small intestinal epithelia from p53-null mice: Evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation
10. Resistance of differentiating spermatogonia to radiation-induced apoptosis and loss in p53-deficient mice
11. p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes
12. Molecular basis of anthracycline-induced cardiotoxicity and its prevention
13. Strategies to prevent nephrotoxicity of anticancer drugs
14. Prediction of normal tissue damage induced by cancer chemotherapy
15. Cisplatin-associated neurotoxicity: Can it be prevented?
16. Cisplatin-induced ototoxicity: The effect of pigmentation, and inhibitory agents
17. Radionuclide injury to the lung
18. Effects of gamma irradiation on dermal equivalents in vitro
19. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo
20. Transgenic mouse model for studying the transcriptional activity of the p53 protein: Age- and tissue-dependent changes in radiation-induced activation during embryogenesis
21. The p53 response to ionising radiation in adult and developing murine tissues
22. p53 is required for radiation-induced apoptosis in mouse thymocytes
23. Thymocyte apoptosis induced by p53-dependent and independent pathways
24. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents
25. p53 dependence of early apoptotic, and proliferative responses within the mouse intestinal epithelium following γ-irradiation
26. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice
27. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia
28. Apoptosis in cancer
29. atm, and p53 cooperate in apoptosis, and suppression of tumorigenesis, but not in resistance to acute radiation toxicity
30. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone
31. Analysis of apoptosis during hair follicle regression (catagen)
32. p53 is essential for chemotherapy-induced hair loss
33. Could p53 be a target for therapeutic suppression?
34. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
35. The treatment of malignancy by hyperthermia
36. Hyperthermia and liposomes
37. Hyperthermia-induced apoptosis occurs both in a p53 gene-dependent and -independent manner in three human gastric carcinoma cell lines
38. Heat shock induces transient p53-dependent cell cycle arrest at G1/S
39. The conditions that induce tumor-suppressor protein p53
40. Heat shock-induced necrosis and apoptosis in osteoblasts
41. Heat-induced G1 arrest is dependent on p53 function but not on RB dephosphorylation
42. Accumulation of mutant p53 and hsp72 by heat treatment, and their association in a human glioblastoma cell line
43. Heat-induced apoptosis and p53 in cultured mammalian cells
44. Thermosensitivity, incidence of apoptosis, and accumulations of hsp72, and p53 proteins of murine L cells in wild type status of p53 gene
45. Susceptibility of AML cells to in vitro apoptosis correlates with heat shock protein 70 (hsp70) expression
46. Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma
47. The dependence of p53 on the radiation enhancement of thermosensitivity at different LET
48. Mild hyperthermia-induced apoptosis is dependent on p53 in human lymphoid cells
49. The morphologic categorization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs
50. A comparison of p53, and p16 expression in human tumor cells treated with hyperthermia or ionizing radiation
51. Transfection of p53-knockout mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress
52. Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member
53. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell
54. Tumor suppressor p53 gene forms multiple isoforms: Evidence for single locus origin and cytoplasmic complex formation with heat shock proteins
55. Geldanamycin prevents nuclear translocation of mutant p53
56. HSP70 binding sites in the tumor suppressor protein p53
57. Binding between wild-type p53 and hsp72 accumulated after UV and γ-ray irradiation
58. Involvement of heat-shock protein 70 and p53 proteins in attenuation of UVC-induced apoptosis by thermal stress in hepatocellular carcinoma cells
59. Induction of heat shock protein 70 protects thymocytes against radiation-induced apoptosis
60. Geldanamycin selectively destabilizes and conformationally alters mutated p53
61. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90
62. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent
63. Flavonoids activate wild-type p53
64. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells
65. Effects of protein kinase inhibitors on the accumulation kinetics of p53 protein in normal human embryo cells following X-irradiation
66. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468
67. Teratogen update: Gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans
68. Hyperthermia, teratogenesis, and the heat shock response in mammalian embryos in culture
69. High-frequency developmental abnormalities in p53-deficient mice
70. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development
71. p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors
72. Expression of p53 during mouse embryogenesis
73. p53-dependent apoptosis suppresses radiation-induced teratogenesis
74. Tumor suppressors: A developing role for p53?
75. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate
76. Improved therapeutic response by distinct timing of multiple heat treatments during interstitial radiation in the Dunning R3327 prostate tumor model
77. Hyperthermia in the multimodal therapy of advanced rectal carcinomas
78. Hyperthermia - Its actual role in radiation oncology. Part III: Clinical rationale, and results in deep seated tumors
79. Hyperthermia and radiation therapy of local-regional recurrent breast cancer: Prognostic factors for response and local control of diffuse or nodular tumors
80. Radiation therapy, Recent advances and nursing implications
81. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia
82. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma
83. Effect of altered duration of 41.5 degrees C whole body hyperthermia in combination with cis-diamminedichloroplatinum (II) on tumor and normal tissue apoptosis and tumor response in rats
84. Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues
85. Apoptosis and p53 protein expression increase in the process of burn wound healing in guinea-pig skin
86. Apoptosis of hair follicle cells in the second-degree burn wound unders hypernatremic conditions
87. Cutaneous burn increases apoptosis in the gut epithelium of mice
88. Major burn trauma in rats promotes cardiac and gastrointestinal apoptosis
89. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor
90. Chinonin, a novel drug against cardiomyocyte apoptosis induced by hypoxia, and reoxygenation
91. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis
92. Redox regulation of p53 during hypoxia
93. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
94. Thrombospondin-1 is downregulated by anoxia, and suppresses tumorigenicity of human glioblastoma cells
95. p53, apoptosis, and human cancers
96. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
97. Cell transforming genes and tumor progression: In vivo unified secondary phenotypic cell changes
98. A role for the tumour suppressor gene p53 in regulating neuronal apoptosis
99. p53 induction is associated with neuronal damage in the central nervous system
100. Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment
101. Nuclear factor κB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum
102. The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53
103. Neuroprotection by neurotrophic factors in apoptosis
104. Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons
105. p53 expression induces apoptosis in hippocampal pyramidal neuron cultures
106. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: Evidence that GAPDH is upregulated by p53
107. Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons
108. p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons
109. Roles of p53, c-Myc, Bcl-2, Bax and caspases in serum deprivation-induced neuronal apoptosis: A possible neuroprotective mechanism of basic fibroblast growth factor
110. Hypoxia-induced apoptosis: Effect of hypoxic severity, and role of p53 in neuronal cell death
111. P53 is essential for developmental neuron death as regulated by the TrkA, and p75 neurotrophin receptors
112. Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death
113. P53-, and CD95-associated apoptosis in neurodegenerative diseases
114. Apoptosis and schizophrenia: Is the tumour suppressor gene, p53, a candidate susceptibility gene?
115. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53
116. Stabilization of wild-type p53 by hypoxia-inducible factor 1α
117. p53 inhibits hypoxia-inducible factor-stimulated transcription
118. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
119. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation
120. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (RelA)-selective targeting
121. Expression of hypoxia-inducible factor 1: Mechanisms and consequences
122. Cellular oxygen sensing by mitochondria: Old questions, new insight
123. Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat
124. p53-immunoreactive protein, and p53 mRNA expression after transient middle cerebral artery occlusion in rats
125. WAF1/Cip1 and PAG608/Wig-1 in ischemic preconditioning
126. Apoptosis and protein expression after focal cerebral ischemia in rat
127. ZFM1/SF1 mRNA in rat, and gerbil brain after global ischaemia
128. WAF1/Cip1 are not markers of neuronal death following transient global cerebral ischemia
129. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice
130. Neural apoptosis
131. Apoptosis in focal cerebral ischemia
132. Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain
133. The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury
134. Changes in apoptosis-related protein (p53, Bax, Bcl-2 and Fos) expression with DNA fragmentation in the central nervous system in rats after closed head injury
135. Postinjury magnesium treatment attenuates traumatic brain injury-induced cortical induction of p53 mRNA in rats
136. Young Investigator's Award, induction of apoptosis following traumatic head injury in humans
137. p53, and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes
138. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system
139. The bcl-2 gene product prevents programmed cell death of ventricular myocytes
140. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53
141. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis
142. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell
143. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes
144. Increased p53 protein expression in human failing myocardium
145. Cardiomyocyte apoptosis with enhanced expression of P53 and Bax in right ventricle after pulmonary arterial banding
146. The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate
147. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
148. ONYX-015: Clinical data are encouraging
149. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
150. MDM2 oncogene as a novel target for human cancer therapy
151. Pharmacological rescue of mutant p53 conformation and function
152. Caspase inhibitors are functionally neuroprotective against oxygen glucose deprivation induced CA1 death in rat organotypic hippocampal slices
153. In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia
154. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats
155. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro
156. Stress-induced secretion of growth inhibitors: A novel tumor suppressor function of p53